Grant: CIHR Fellowship
Direct Payment
$150,000.00
Characterization of the dynamin I - endophilin interaction in clathrin mediated endocytosis.
EF 2009-10
Résumé
Communication between neurons is mediated by the release of synaptic vesicles (SVs) containing neurotransmitter from the presynaptic nerve terminal. Two methods of SV endocytosis - clathrin mediated endocytosis (CME) and activity dependent bulk endocytosis (ADBE) are required to prevent synaptic fatigue at different levels of activity. However, the mechanisms regulating the switch between CME and ADBE are unknown. Recent studies suggest that dynaminI (dynI), a large GTPase enzyme, is a key component of this switch. Two isoforms of dynI known as dynIxa and dynIxb, with a long and short C-terminal tail respectively, are expressed in neurons. Differences in the tail sequences suggest they play a role in specifying the recruitment of distinct binding partners. In particular, dynIxa has an additional binding site for the SVE protein endophilin. Here we will test the hypothesis that the interaction between dyn1xa and endophilin is required for CME rather than ADBE. We will express mutants of dynIxa in cerebellar granule cells from wild-type or dynI knock-out mice and determine their effect on CME. Using fluorescent styryl dyes for live cell imaging, or horseradish peroxidase for electron microscopy we will monitor uptake and distinguish between CME and ADBE. We will also develop peptide mimetics to block binding between dynIxa and endophilin to determine if the interaction is specifically required for CME. By characterizing the unique role of a dynI splice variant in SVE we will advance our understanding of the regulation of synaptic transmission. This knowledge can subsequently be applied to the treatment of diseases such as Alzheimer's disease and epilepsy.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Australia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
193008
Name
Miller Linda C
Country
Australia
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Characterization of the dynamin I - endophilin interaction in clathrin mediated endocytosis.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Dynamin I; Endocytosis; Endophilin; Knock-Out Mice; Splice Variants; Synaptic Vesicles
Abstract
Communication between neurons is mediated by the release of synaptic vesicles (SVs) containing neurotransmitter from the presynaptic nerve terminal. Two methods of SV endocytosis - clathrin mediated endocytosis (CME) and activity dependent bulk endocytosis (ADBE) are required to prevent synaptic fatigue at different levels of activity. However, the mechanisms regulating the switch between CME and ADBE are unknown. Recent studies suggest that dynaminI (dynI), a large GTPase enzyme, is a key component of this switch. Two isoforms of dynI known as dynIxa and dynIxb, with a long and short C-terminal tail respectively, are expressed in neurons. Differences in the tail sequences suggest they play a role in specifying the recruitment of distinct binding partners. In particular, dynIxa has an additional binding site for the SVE protein endophilin. Here we will test the hypothesis that the interaction between dyn1xa and endophilin is required for CME rather than ADBE. We will express mutants of dynIxa in cerebellar granule cells from wild-type or dynI knock-out mice and determine their effect on CME. Using fluorescent styryl dyes for live cell imaging, or horseradish peroxidase for electron microscopy we will monitor uptake and distinguish between CME and ADBE. We will also develop peptide mimetics to block binding between dynIxa and endophilin to determine if the interaction is specifically required for CME. By characterizing the unique role of a dynI splice variant in SVE we will advance our understanding of the regulation of synaptic transmission. This knowledge can subsequently be applied to the treatment of diseases such as Alzheimer's disease and epilepsy.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Miller, Linda C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~